http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4704484

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't
endingPage 268
issn 0169-5002
pageRange 259-268
publicationName Lung cancer (Amsterdam, Netherlands)
startingPage 259
bibliographicCitation Wang Z, Zhao J, Ma Z, Cui J, Shu Y, Liu Z, Cheng Y, Leaw SJ, Wu Y, Ma Y, Tan W, Ma X, Zhang Y, Wang J. A Phase 2 Study of Tislelizumab in Combination With Platinum-Based Chemotherapy as First-line Treatment for Advanced Lung Cancer in Chinese Patients. Lung Cancer. 2020 Sep;147():259–68. doi: 10.1016/j.lungcan.2020.06.007. PMID: 32769013.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7babbc4b70dca0914b3fd851c717aa7c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69a817e2a2c253ce2b2099443dd9d043
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1c96e32761d17eb69ff426a17c8b85f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7722-4956
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48698b7c861ae1f0646b6ef4592a3308
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efaa34a12cb58d751cbbdb91af94b43f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_414a4dbce3504560f16a6be319929851
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27232e87dcb3b681077f91d7441ab78f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1ecba137e2a5f849a82ebe5b189f79b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7308092735530b002e96e49c2bdaada5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e47166412dbb16648fc410098a44034b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43c5a7cb0e34024f43faecee281a9201
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ac62de74deb874f1d4ab94bdc1b1776
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d871e2ac245d1cfba5bab0d04359fad
date 202009
identifier https://pubmed.ncbi.nlm.nih.gov/32769013
https://doi.org/10.1016/j.lungcan.2020.06.007
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8534
https://portal.issn.org/resource/ISSN/0169-5002
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A Phase 2 Study of Tislelizumab in Combination With Platinum-Based Chemotherapy as First-line Treatment for Advanced Lung Cancer in Chinese Patients
discusses http://id.nlm.nih.gov/mesh/M000734928
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0017026
http://id.nlm.nih.gov/mesh/M0227083
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000068437Q000627
http://id.nlm.nih.gov/mesh/D010984Q000627
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D002681
http://id.nlm.nih.gov/mesh/D000971Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750

Total number of triples: 56.